Bottom line
What does PHPIX hold?
PHPIX held 74 positions as of Jul 31, 2026. Its largest holding is N/a at 8.20% of the fund, and the top 10 positions add up to 39.1%. By asset type it is 71% stocks, 30% repurchase agreements.
Updated Sep 23, 2026
PHPIX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | N/a SOCIETE' GENERALE 3.53 , 8/03/2026 |
Repurchase agreements | 8.20% | $703.0K |
| 2 | N/a CF Secured 3.53 , 8/03/2026 |
Repurchase agreements | 6.31% | $541.0K |
| 3 | N/a HSBC SECURITIES (USA), INC. 3.52 , 8/03/2026 |
Repurchase agreements | 5.05% | $433.0K |
| 4 | N/a NATWEST MARKETS PLC 3.51 , 8/03/2026 |
Repurchase agreements | 5.05% | $433.0K |
| 5 | N/a UMB FINANCIAL CORP. 3.39 , 8/03/2026 |
Repurchase agreements | 3.95% | $339.0K |
| 6 | Crinetics Pharmaceuticals Inc Crinetics Pharmaceuticals, Inc. |
Stocks | 2.60% | $223.4K |
| 7 | Mbx Biosciences Inc MBX Biosciences, Inc. |
Stocks | 2.28% | $195.4K |
| 8 | Ataibeckley Inc AtaiBeckley, Inc. |
Stocks | 2.03% | $174.4K |
| 9 | Definium Therapeutics Inc Definium Therapeutics, Inc. |
Stocks | 2.00% | $171.9K |
| 10 | Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals, Inc. |
Stocks | 1.62% | $138.5K |
| 11 | Enliven Therapeutics Inc Enliven Therapeutics, Inc. |
Stocks | 1.59% | $136.0K |
| 12 | Corcept Therapeutics Inc Corcept Therapeutics, Inc. |
Stocks | 1.57% | $134.5K |
| 13 | Alumis Inc Alumis, Inc. |
Stocks | 1.51% | $129.3K |
| 14 | N/a ROYAL BANK OF CANADA 3.44 , 8/03/2026 |
Repurchase agreements | 1.49% | $128.0K |
| 15 | Nuvation Bio Inc Nuvation Bio, Inc. |
Stocks | 1.48% | $126.9K |
| 16 | Trevi Therapeutics Inc Trevi Therapeutics, Inc. |
Stocks | 1.46% | $125.0K |
| 17 | Liquidia Corp Liquidia Corporation |
Stocks | 1.38% | $118.3K |
| 18 | Nektar Therapeutics Nektar Therapeutics |
Stocks | 1.33% | $114.3K |
| 19 | Amneal Pharmaceuticals Inc Amneal Pharmaceuticals, Inc. |
Stocks | 1.28% | $109.8K |
| 20 | Bristol-myers Squibb Company Bristol-Myers Squibb Company |
Stocks | 1.26% | $107.8K |
| 21 | Edgewise Therapeutics Inc Edgewise Therapeutics, Inc. |
Stocks | 1.25% | $107.2K |
| 22 | Omeros Corp Omeros Corporation |
Stocks | 1.24% | $106.6K |
| 23 | Ligand Pharmaceuticals Inc Ligand Pharmaceuticals, Inc. |
Stocks | 1.24% | $106.4K |
| 24 | Elanco Animal Health Inc Elanco Animal Health, Inc. |
Stocks | 1.23% | $105.8K |
| 25 | Veradermics Inc VeraDermics, Inc. |
Stocks | 1.21% | $103.6K |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 23, 2026